Browne, MD. In this video, Brendan M. Browne, MD, discusses which patients may be best suited to undergo HoLEP for benign prostatic hyperplasia (BPH). Browne is an assistant professor of urology at ...

Both Original Medicare and Medicare Advantage cover Rezum water vapor therapy for lower urinary tract symptoms related to benign prostatic hyperplasia (also known as an enlarged prostate).

[16,17] Blockade of these receptors relaxes the smooth muscle of the prostate and bladder neck without blocking vascular receptors. Tamsulosin is currently the only third-generation uroselective ...

Sensitivity analysis results indicate that the overall budget for the treatment of BPH increases with use of DUT + TAM FDC compared to tamsulosin monotherapy during the 4 year study period ...

The approval was based on results from a 24-week Phase III study of Gemtesa versus placebo in around 1,100 men with OAB symptoms receiving pharmacologic therapy for BPH. All co-primary end points ...

I went to urgent care and was then sent to an imaging center. My prostate gland wasn’t appreciably enlarged, so I was sent to the emergency room and had a catheter inserted. My primary doctor ...